Journal
ONCOTARGET
Volume 7, Issue 27, Pages 42579-42584Publisher
IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.9938
Keywords
automatic delineation software; rectal cancer; rectal cancer delineation; independent check; clinical use of automatic delineation software
Categories
Funding
- NCI NIH HHS [P30 CA016672] Funding Source: Medline
Ask authors/readers for more resources
To validate autocontouring software (AS) in a clinical practice including a two steps delineation quality assurance (QA) procedure. The existing delineation agreement among experts for rectal cancer and the overlap and time criteria that have to be verified to allow the use of AS were defined. Median Dice Similarity Coefficient (MDSC), Mean slicewise Hausdorff Distances (MSHD) and Total-Time saving (TT) were analyzed. Two expert Radiation Oncologists reviewed CT-scans of 44 patients and agreed the reference-CTV: the first 14 consecutive cases were used to populate the software Atlas and 30 were used as Test. Each expert performed a manual (group A) and an automatic delineation (group B) of 15 Test patients. The delineations were compared with the reference contours. The overlap between the manual and automatic delineations with MDSC and MSHD and the TT were analyzed. Three acceptance criteria were set: MDSC >= 0.75, MSHD >= 1mm and TT sparing >= 50%. At least 2 criteria had to be met, one of which had to be TT saving, to validate the system. The MDSC was 0.75, MSHD 2.00 mm and the TT saving 55.5% between group A and group B. MDSC among experts was 0.84. Autosegmentation systems in rectal cancer partially met acceptability criteria with the present version.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available